female scientist inspecting beaker

Research & Data

ASCO advances clinical research through scientific meetings, educational programs, and peer-reviewed journals designed to help translate research results into quality care.

  • New Telehealth in Oncology Standards

    ASCO has issued a new set of practice standards: Telehealth in Oncology. These standards provide general guidance on implementing telehealth across general and specialty settings in the oncology field.

    Learn More
  • Newly Updated HER2-Negative Metastatic Breast Cancer Guideline

    The guideline, "Chemo- and Targeted Therapy for Patients with HER2-Negative Metastatic Breast Cancer" is now available. Recommendations include immune checkpoint inhibitor may be added to chemotherapy as first-line therapy for patients with metastatic triple-negative breast cancer positive for PD-L1.

    Read More

Random Quote

"ASCO is leading the move to a new data-driven era of discovery in clinical oncology."
Peter Paul Yu, MD, FACP, FASCO
ASCO President, 2014-15